WHO-South Korea biomanufacturing training hub initiative (September 2022)
Generic and Biosimilar Medicines, Central to Patient Health and Global Healthcare Policies (September 2022)
Experts and leaders from the local and global generic and biosimilar medicines industry, Government and UN agencies, patient organizations, academia and other stakeholders are meeting from 7 to 9 September in Kuala Lumpur, Malaysia to discuss key topics affecting worldwide patient access to affordable medicines, such as...
More Articles...
- ViiV Healthcare and the Medicines Patent Pool sign new voluntary licensing agreement to expand access to innovative long-acting HIV prevention medicine (28 July 2022)
- UICC announces a new global coalition to increase access to and the use of essential cancer medicines in low- and lower middle-income countries (May 2022)
- IGBA’s Newly Launched CEO Advisory Committee Holds Inaugural Meeting with WTO Director General (May 2022)
- IGBA establishes a CEO Advisory Committee (February 2022, Committee updated)
